Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...
TAG24 NEWS on MSN5m
Major study of weight-loss jabs shows slew of benefits but also risks
Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...